Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

NCT02452216 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Brain Injury
Central Nervous System Degenerative Disorder
Central Nervous System Infectious Disorder
Central Nervous System Vascular Malformation
Hemorrhagic Cerebrovascular Accident
Ischemic Cerebrovascular Accident
Primary Brain Neoplasm
Brain Cancer
Brain Tumors

Interventions

DRUG: Ferumoxytol
OTHER: Tissue Analysis
PROCEDURE: Magnetic Resonance Imaging

Sponsor

Michael Iv